Shenzhen New Industries Biomedical Engineering Co., Ltd. (300832.SZ)
CNY 66.33
(-2.11%)
CNY 66.33
(-2.11%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 971.76 Million CNY | 30.21% |
| 2022 | 772.58 Million CNY | 6.72% |
| 2021 | 723.93 Million CNY | 16.84% |
| 2020 | 619.57 Million CNY | 29.83% |
| 2019 | 477.23 Million CNY | 36.75% |
| 2018 | 348.97 Million CNY | 30.68% |
| 2017 | 267.04 Million CNY | 9.55% |
| 2016 | 243.77 Million CNY | -16.81% |
| 2015 | 293.02 Million CNY | 113.98% |
| 2014 | 136.93 Million CNY | 23.9% |
| 2013 | 110.52 Million CNY | 26.37% |
| 2012 | 87.45 Million CNY | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q3 | 345.67 Million CNY | 13.39% |
| 2024 Q1 | 298.33 Million CNY | 29.83% |
| 2024 Q2 | 283.27 Million CNY | -5.05% |
| 2023 Q1 | 212.39 Million CNY | 75.51% |
| 2023 FY | 1 Billion CNY | 30.21% |
| 2023 Q4 | 229.78 Million CNY | -21.36% |
| 2023 Q3 | 292.21 Million CNY | -9.36% |
| 2023 Q2 | 322.39 Million CNY | 51.79% |
| 2022 FY | 772.58 Million CNY | 6.72% |
| 2022 Q1 | 180.89 Million CNY | 50.0% |
| 2022 Q4 | 121.01 Million CNY | -52.03% |
| 2022 Q3 | 252.27 Million CNY | 15.51% |
| 2022 Q2 | 218.4 Million CNY | 20.74% |
| 2021 FY | 723.93 Million CNY | 16.84% |
| 2021 Q4 | 120.59 Million CNY | -42.25% |
| 2021 Q3 | 208.82 Million CNY | 6.07% |
| 2021 Q1 | 197.64 Million CNY | 9.52% |
| 2021 Q2 | 196.87 Million CNY | -0.39% |
| 2020 Q1 | 95.42 Million CNY | -34.94% |
| 2020 Q4 | 180.45 Million CNY | -6.79% |
| 2020 FY | 619.57 Million CNY | 29.83% |
| 2020 Q2 | 150.08 Million CNY | 57.27% |
| 2020 Q3 | 193.6 Million CNY | 29.0% |
| 2019 Q3 | 124.74 Million CNY | 7.68% |
| 2019 Q2 | 115.85 Million CNY | 28.79% |
| 2019 Q1 | 89.95 Million CNY | 0.0% |
| 2019 Q4 | 146.67 Million CNY | 17.57% |
| 2019 FY | 477.23 Million CNY | 36.75% |
| 2018 FY | 348.97 Million CNY | 30.68% |
| 2017 FY | 267.04 Million CNY | 9.55% |
| 2016 Q1 | 46.52 Million CNY | -49.31% |
| 2016 FY | 243.77 Million CNY | -16.81% |
| 2016 Q4 | 57.5 Million CNY | 0.0% |
| 2016 Q3 | 57.5 Million CNY | 23.6% |
| 2016 Q2 | 46.52 Million CNY | 0.0% |
| 2015 Q3 | 91.77 Million CNY | 115.51% |
| 2015 Q2 | 42.58 Million CNY | 0.0% |
| 2015 Q1 | 42.58 Million CNY | 36.17% |
| 2015 Q4 | 91.77 Million CNY | 0.0% |
| 2015 FY | 293.02 Million CNY | 113.98% |
| 2014 FY | 136.93 Million CNY | 23.9% |
| 2014 Q2 | 28.67 Million CNY | -0.0% |
| 2014 Q1 | 28.67 Million CNY | -8.25% |
| 2014 Q4 | 31.27 Million CNY | 0.0% |
| 2014 Q3 | 31.27 Million CNY | 9.05% |
| 2013 Q2 | 23.54 Million CNY | -0.0% |
| 2013 Q4 | 31.25 Million CNY | 0.0% |
| 2013 FY | 110.52 Million CNY | 26.37% |
| 2013 Q3 | 31.25 Million CNY | 32.78% |
| 2013 Q1 | 23.54 Million CNY | 0.0% |
| 2012 FY | 87.45 Million CNY | 0.0% |